clinical tool to identify older women with back pain at high risk of osteoporotic vertebral fractures (Vfrac): a population-based cohort study with exploratory economic evaluation.

Background osteoporotic vertebral fractures (OVFs) identify people at high risk of future fractures, but despite this, less than a third come to clinical attention. The objective of this study was to develop a clinical tool to aid health care professionals decide which older women with back pain sho...

Descripción completa

Detalles Bibliográficos
Publicado en:Age & Ageing Vol. 51; no. 3; pp. 1 - 9
Autores principales: Khera, Tarnjit, Hunt, Linda P, Davis, Sarah, Gooberman-Hill, Rachael, Thom, Howard, Xu, Yixin, Paskins, Zoe, Peters, Tim J, Tobias, Jon H, Clark, Emma M
Formato: Artículo
Publicado: Oxford University Press / USA Mar2022
Materias:
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Background osteoporotic vertebral fractures (OVFs) identify people at high risk of future fractures, but despite this, less than a third come to clinical attention. The objective of this study was to develop a clinical tool to aid health care professionals decide which older women with back pain should have a spinal radiograph. Methods a population-based cohort of 1,635 women aged 65+ years with self-reported back pain in the previous 4 months were recruited from primary care. Exposure data were collected through self-completion questionnaires and physical examination, including descriptions of back pain and traditional risk factors for osteoporosis. Outcome was the presence/absence of OVFs on spinal radiographs. Logistic regression models identified independent predictors of OVFs, with the area under the (receiver operating) curve calculated for the final model, and a cut-point was identified. Results mean age was 73.9 years and 209 (12.8%) had OVFs. The final Vfrac model comprised 15 predictors of OVF, with an AUC of 0.802 (95% CI: 0.764–0.840). Sensitivity was 72.4% and specificity was 72.9%. Vfrac identified 93% of those with more than one OVF and two-thirds of those with one OVF. Performance was enhanced by inclusion of self-reported back pain descriptors, removal of which reduced AUC to 0.742 (95% CI: 0.696–0.788) and sensitivity to 66.5%. Health economic modelling to support a future trial was favourable. Conclusions the Vfrac clinical tool appears to be valid and is improved by the addition of self-reported back pain symptoms. The tool now requires testing to establish real-world clinical and cost-effectiveness.